Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Walker

Showing results (221-230 of 260) with videos related to

Pageof 26
Sort By:
Genome Medicine|April 14, 2025
Systematic identification of disease-causing promoter and untranslated region variants in 8040 undiagnosed individuals with rare diseaseAlexandra C Martin-Geary, Alexander J M Blakes, Ruebena Dawes, et al.
American Journal of Human Genetics|January 3, 2012
Rare deletions at the neurexin 3 locus in autism spectrum disorderAndrea K Vaags, Anath C Lionel, Daisuke Sato, et al.
Molecular Psychiatry|February 23, 2018
Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signalingMelanie Richter, Nadeem Murtaza, Robin Scharrenberg, et al.
Nature Medicine|January 27, 2015
Whole-genome sequencing of quartet families with autism spectrum disorderRyan K C Yuen, Bhooma Thiruvahindrapuram, Daniele Merico, et al.
Scientific Reports|July 2, 2016
Indexing Effects of Copy Number Variation on Genes Involved in Developmental DelayMohammed Uddin, Giovanna Pellecchia, Bhooma Thiruvahindrapuram, et al.
Nature Medicine|January 10, 2024
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer ProgrammeAlona Sosinsky, John Ambrose, William Cross, et al.
American Journal of Human Genetics|April 17, 2012
SHANK1 Deletions in Males with Autism Spectrum DisorderDaisuke Sato, Anath C Lionel, Claire S Leblond, et al.
BMC Pregnancy and Childbirth|January 13, 2021
A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trialWilliam M Hague, Leonie Callaway, Jennifer Chambers, et al.
Clinical Genetics|April 9, 2026
Comprehensive Assessment of the KDM2B-Associated Neurodevelopmental Disorder and the 12q24.31 Microdeletion SyndromeAmber S E van Oirsouw, Tzung-Chien Hsieh, Martijn Koetsier, et al.
Human Molecular Genetics|February 9, 2013
Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizuresAnath C Lionel, Andrea K Vaags, Daisuke Sato, et al.
Pageof 26

Showing results (221-230 of 260) with videos related to

Sort By:
Pageof 26
Genome Medicine|April 14, 2025
Systematic identification of disease-causing promoter and untranslated region variants in 8040 undiagnosed individuals with rare diseaseAlexandra C Martin-Geary, Alexander J M Blakes, Ruebena Dawes, et al.
American Journal of Human Genetics|January 3, 2012
Rare deletions at the neurexin 3 locus in autism spectrum disorderAndrea K Vaags, Anath C Lionel, Daisuke Sato, et al.
Molecular Psychiatry|February 23, 2018
Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signalingMelanie Richter, Nadeem Murtaza, Robin Scharrenberg, et al.
Nature Medicine|January 27, 2015
Whole-genome sequencing of quartet families with autism spectrum disorderRyan K C Yuen, Bhooma Thiruvahindrapuram, Daniele Merico, et al.
Scientific Reports|July 2, 2016
Indexing Effects of Copy Number Variation on Genes Involved in Developmental DelayMohammed Uddin, Giovanna Pellecchia, Bhooma Thiruvahindrapuram, et al.
Nature Medicine|January 10, 2024
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer ProgrammeAlona Sosinsky, John Ambrose, William Cross, et al.
American Journal of Human Genetics|April 17, 2012
SHANK1 Deletions in Males with Autism Spectrum DisorderDaisuke Sato, Anath C Lionel, Claire S Leblond, et al.
BMC Pregnancy and Childbirth|January 13, 2021
A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trialWilliam M Hague, Leonie Callaway, Jennifer Chambers, et al.
Clinical Genetics|April 9, 2026
Comprehensive Assessment of the KDM2B-Associated Neurodevelopmental Disorder and the 12q24.31 Microdeletion SyndromeAmber S E van Oirsouw, Tzung-Chien Hsieh, Martijn Koetsier, et al.
Human Molecular Genetics|February 9, 2013
Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizuresAnath C Lionel, Andrea K Vaags, Daisuke Sato, et al.
Pageof 26